• Vertex Pharmaceuticals (MA) (VRTX) Goes From Bad Data to a Bad Promotion More...

• 1 in 4 Medical Sales Job Seekers Forced into Job Search More...

• AssureRx Raises $12.5 Million Series C Financing More...

• GlaxoSmithKline (GSK) Eyes Replacing Human Genome Sciences, Inc. (HGSI) Board More...

• UCB, Inc. (UCBJF.PK) Takes Majority Stake in Brazil's Meizler More...

• Catalent Pharma Solutions Enters Agreement to Sell Its U.S. Commercial Packaging Operations More...

• AptarGroup to Expand Pharma Solutions Portfolio With the Acquisition of theStelmi Group, a Primary Packaging Components Maker More...

• GlaxoSmithKline (GSK)'s Stiefel Laboratories Pays Welichem Biotech Inc. (WBI.V) $50 Million for Topical Agent for Psoriasis, Atopic Dermatitis More...

• Bayer HealthCare (BAY), Covance Inc. (CVD) Ink Drug Development Pact More...

• Affymetrix (Santa Clara, California) (AFFX) and Leica Microsystems Announce Worldwide Collaboration on Automated, Single-Copy, RNA In Situ Hybridization (ISH) Tissue Assay for Research Use More...

• Icahn Takes Another Run at Forest Laboratories, Inc. (FRX) Board More...

• Polynoma Appoints John Chiplin, Ph.D., Chief Executive Officer More...

• Swedish Orphan Biovitrum Appoints Birgitte Volck as Chief Medical Officer More...

• Molecular Partners AG Strengthens Management Team With the Appointment of Lisa Rojkjaer, MD as Chief Medical Officer More...

• Zyngenia Appoints Frank Hsu, M.D., as Chief Medical Officer More...

• BioReference Laboratories, Inc. (BRLI) Announces Earnings Date for Second Quarter Fiscal Year 2012 More...

• GlaxoSmithKline (GSK) Partner Pronova BioPharma Wins Lovaza Patent Case Against Teva Pharmaceutical Industries Limited (TEVA) & Par Pharmaceutical, Inc. More...

• Pfizer Inc. (PFE) Cleared of Liability in Prempro Breast Cancer Case More...

• Change in Date of Anticipated Arbitration Decision in Sucampo Pharmaceuticals, Inc. Dispute More...

• Infectious Disease Research Institute (IDRI) Signs Lease with Alexandria Real Estate Equities, Inc. for New Seattle Headquarters More...

• Chelsea Therapeutics, Inc. (CHTP) Plunges as RA Study Fails More...

• RXi Pharmaceuticals (RXII) Receives FDA Clearance to Begin Clinical Trial With RXI-109 More...

• Eli Lilly and Company (LLY) and Kowa Pharmaceuticals America Reveal Positive Results of PREVAIL US Study More...

• Rockwell Medical Technologies (RMTI) Completes Patient Enrollment in CRUISE-1 Phase III Clinical Study More...

• AEterna Zentaris (AEZS): Article on Perifosine as Potential Novel Approach to the Treatment of Mesothelioma Published in Plos One More...

• A.P. Pharma, Inc. (APPA) Announces Study Finding Continuous Exposure to a 5-HT3 Antagonist Using APF530 Provides Better Emetic Control More...

• ImmunoCellular Therapeutics, Ltd to Present Long-term Survival Data from Clinical Study of ICT-107 in Glioblastoma Multiforme at American Society of Clinical Oncology Meeting More...

• Oregon Health & Science University (OHSU) Researchers Say Tart Cherries Have "the Highest Anti-Inflammatory Content of Any Food" More...

• Humans Can Sniff Out Old Age in Others, Monell Chemical Senses Center Study More...

• New Research Shows Runners Can Improve Health and Performance With Less Training, University of Copenhagen Study More...

• Exercise and a Healthy Diet of Fruits and Vegetables Extends Life Expectancy in Women in Their 70s, University of Michigan Study More...

• Ketamine Improved Bipolar Depression Within Minutes, National Institute of Mental Health Study More...

• La Jolla Pharmaceutical Company (LJPC) Announces Issuance of U.S. Patent Covering Modified Pectin Compositions More...

• Rhenovia Files Patents for New Treatment of Huntington's Disease Based on Its Innovative Biosimulation Platform More...

• Supplies of Maalox Dwindling Across Canada Caused by Novartis AG (NVS) Shutdown More...

• Pfizer Canada Inc. Release: New Personalized Medicine for ALK-positive Advanced or Metastatic Non-small Cell Lung Cancer More...

• Nouveau Life Pharmaceuticals (NOUV) Announces Release of Its Female Supplement More...